Direct binding of Cbl to Tyr(568) and Tyr(936) of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation

Tekijä Masson, Kristina, Heiss, Elke, Band, Hamid, Rönnstrand, Lars
Julkaistu 2006

Predicting ligand-dependent tumors from multi-dimensional signaling features

Tekijä Hass, Helge, Masson, Kristina, Wohlgemuth, Sibylle, Paragas, Violette, Allen, John E., Sevecka, Mark, Pace, Emily, Timmer, Jens, Stelling, Joerg, MacBeath, Gavin, Schoeberl, Birgit, Raue, Andreas
Julkaisussa NPJ Syst Biol Appl (2017)

Protein-tyrosine Phosphatase DEP-1 Controls Receptor Tyrosine Kinase FLT3 Signaling

Tekijä Arora, Deepika, Stopp, Sabine, Böhmer, Sylvia-Annette, Schons, Julia, Godfrey, Rinesh, Masson, Kristina, Razumovskaya, Elena, Rönnstrand, Lars, Tänzer, Simone, Bauer, Reinhard, Böhmer, Frank-D., Müller, Jörg P.
Julkaistu 2011

A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells

Tekijä Weïwer, Michel, Spoonamore, James, Wei, Jingqiang, Guichard, Boris, Ross, Nathan T., Masson, Kristina, Silkworth, Whitney, Dandapani, Sivaraman, Palmer, Michelle, Scherer, Christina A., Stern, Andrew M., Schreiber, Stuart L., Munoz, Benito
Julkaistu 2012

STK33 kinase inhibitor BRD-8899 has no effect on KRAS-dependent cancer cell viability

Tekijä Luo, Tuoping, Masson, Kristina, Jaffe, Jacob D., Silkworth, Whitney, Ross, Nathan T., Scherer, Christina A., Scholl, Claudia, Fröhling, Stefan, Carr, Steven A., Stern, Andrew M., Schreiber, Stuart L., Golub, Todd R.
Julkaistu 2012

MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM

Tekijä Casaletto, Jessica B., Geddie, Melissa L., Abu-Yousif, Adnan O., Masson, Kristina, Fulgham, Aaron, Boudot, Antoine, Maiwald, Tim, Kearns, Jeffrey D., Kohli, Neeraj, Su, Stephen, Razlog, Maja, Raue, Andreas, Kalra, Ashish, Håkansson, Maria, Logan, Derek T., Welin, Martin, Chattopadhyay, Shrikanta, Harms, Brian D., Nielsen, Ulrik B., Schoeberl, Birgit, Lugovskoy, Alexey A., MacBeath, Gavin
Julkaisussa Proc Natl Acad Sci U S A (2019)

Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121)

Tekijä Schoeberl, Birgit, Kudla, Art, Masson, Kristina, Kalra, Ashish, Curley, Michael, Finn, Gregory, Pace, Emily, Harms, Brian, Kim, Jaeyeon, Kearns, Jeff, Fulgham, Aaron, Burenkova, Olga, Grantcharova, Viara, Yarar, Defne, Paragas, Violette, Fitzgerald, Jonathan, Wainszelbaum, Marisa, West, Kip, Mathews, Sara, Nering, Rachel, Adiwijaya, Bambang, Garcia, Gabriela, Kubasek, Bill, Moyo, Victor, Czibere, Akos, Nielsen, Ulrik B, MacBeath, Gavin
Julkaisussa NPJ Syst Biol Appl (2017)